YOLFTbeta
01

Malaysian Genomics Resource

0155 · KLSE · Healthcare / Diagnostics & Research

0.305MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.305
Open0.305
Day Range0.305 – 0.305
52-Week Range0.155 – 0.385
Volume70.50K
Market Cap52.83M
P/E (TTM)0.00
Forward P/E7.84
EPS0.00
Dividend Yield0.00%
Beta0.14
50-Day Avg0.3403
200-Day Avg0.2514

About

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia. The company offers genetic screening services that includes Dtect and Origene genetic testing solutions which provides individuals with insights into genetic predispositions related to health risks, wellness, and lifestyle traits. It also provides immunotherapy and cell therapy which offers mesenchymal stem cells derived from ethically sourced human umbilical cords, as well as natural killer cell therapies designed to strengthen the body's immune response that are relevant in the treatment of cancers, autoimmune diseases, and other complex conditions. In addition, the company offers genome sequencing and bioinformatics services; personalized supplements; cellular therapy for regenerative health; and cell-free therapy for regeneration and repair. Further, it is involved in dealing in capital markets and derivative instruments; acting as general merchants; research, development, and commercialization of biopharmaceutical products and services; business relating to life sciences/cell lab and by products; and distribution of healthcare products, beauty products, and precision medicine. Additionally, the company provides system developments and information technology comprising software and hardware, as well as other human health services and general medical services. Malaysian Genomics Resource Centre Berhad was incorporated in 2004 and is headquartered in Petaling Jaya, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Yien Hung Leong
  • Employees33
  • HeadquartersJalan Teknologi 3/6, Petaling Jaya, Malaysia, 47810, Malaysia
  • Websitehttps://www.mgrc.com.my

Leadership

  • Mr. Yien Hung LeongExecutive Chairman & MD · b. 1984
  • Mr. Tong Lang TanCompany Secretary · b. 1978
  • Lee Mee ThienCompany Secretary

Financials

Income Statement

Currency: MYR2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue13.90M10.43M9.87M26.16M283.06K951.35K1.78M28.36M8.36M12.86M5.52M8.02M
Growth (%)--24.93%-5.37%+164.95%-98.92%+236.09%+87.47%+1490.09%-70.51%+53.76%-57.06%+45.29%
Cost of Revenue-1.17M2.96M17.02M400.89K328.09K570.80K14.51M3.26M5.36M2.09M2.88M
Gross Profit-9.26M6.92M9.14M-117.83K623.26K1.21M13.85M5.10M7.50M3.43M5.14M
Gross Margin-88.75%70.06%34.95%-41.63%65.51%68.00%48.84%60.98%58.34%62.09%64.08%
Operating Expense-7.59M6.34M12.85M4.63M6.67M5.41M7.57M18.69M29.89M7.82M5.87M
Operating Income2.74M1.67M578.01K-3.71M-4.74M-6.05M-4.20M6.28M-13.59M-22.39M-4.40M-728.95K
Operating Margin19.75%16.01%5.85%-14.17%-1676.15%-635.54%-235.47%22.16%-162.47%-174.09%-79.59%-9.09%
EBITDA--1.48M-2.12M-1.40M-4.37M-3.62M7.42M---2.82M-925.11K
EBITDA Margin--14.96%-8.12%-496.13%-459.18%-202.72%26.16%---51.08%-11.53%
Net Income3.62M1.74M589.30K-4.53M-3.84M17.10M-4.29M7.21M-14.25M-21.51M-4.19M-2.38M
Net Income Margin26.07%16.67%5.97%-17.34%-1356.55%1797.48%-240.70%25.43%-170.33%-167.30%-75.90%-29.68%
R&D-3.90K----------
R&D as % of Total Revenue-0.04%----------
Interest Expense0000961.67K396.06K93.27K102.00K96.00K-119.18K95.53K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%339.74%41.63%5.23%0.36%1.15%-2.16%1.19%

Balance Sheet

Currency: MYR2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets21.72M21.47M37.80M40.84M37.00M11.09M22.78M41.89M30.87M25.70M22.36M18.71M
Total Liabilities4.07M2.08M13.49M21.07M21.07M827.98K4.85M4.84M4.08M3.36M4.20M3.92M
Total Equity17.65M19.39M24.30M19.77M15.93M10.26M17.93M37.05M26.79M22.35M18.16M15.77M
Cash-4.05M1.88M7.38M4.33M6.08M11.31M20.52M1.69M1.42M270.76K1.02M
Total Debt--4.50M14.67M14.22M-1.30M-----
Net Debt---3.11M6.06M-------

Cash Flow

Currency: MYR2012-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-395.83K3.68M3.67M-6.34M-687.64K11.67M-2.64M56.92K-22.07M-24.97M-744.97K1.10M
Investing Cash Flow--2.54M70.10K-11.58M-1.82M-1.13M31.17M-3.89M-2.44M-381.00K-530.52K-178.53K-
Financing Cash Flow---4.32M12.57M194.88K-40.02M11.75M11.59M3.62M6.40M-228.96K-
Capital Expenditure0318.34K181.42K143.49K938.32K2.21M351.18K3.96M1.33M442.00K596.52K208.10K71.64K
Free Cash Flow---3.53M-7.28M-2.90M9.47M-6.60M-1.27M-21.21M--953.07K1.03M
Dividends Paid------22.77M0-----
FCF to OCF---96.10%114.80%422.03%81.18%250.31%-2237.72%96.14%-127.93%93.52%
Dividend Paid to FCF------240.41%0.00%-----

Earnings

Report DateDec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Aug 30, 2022Nov 22, 2022Feb 24, 2023May 23, 2023Aug 28, 2023Nov 28, 2023Feb 28, 2024May 23, 2024Aug 28, 2024Nov 27, 2024Feb 27, 2025May 26, 2025Aug 27, 2025Nov 26, 2025Feb 27, 2026May 26, 2026Sep 2, 2026
EPS Estimate---------------------------------------------------------------
EPS Actual0.010.010.010.00-0.02-0.01-0.02-0.03-0.03-0.03-0.01-0.02-0.01-0.020.000.010.010.010.010.010.010.000.000.01-0.00-0.000.00-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.000.23-0.02-0.05-0.01-0.010.00-0.020.000.010.020.030.01-0.010.03-0.08-0.01-0.08-0.01-0.01-0.01-0.00-0.01-0.000.00-0.010.010.00
Surprise---------------------------------------------------------------
Timing-------------------------------------------------Pre-marketPre-market--Pre-market--Pre-marketPre-market-----

Key Statistics & Ratios

Market Cap52.83M
Enterprise Value49.60M
Trailing P/E0.00
Forward P/E7.84
Price / Sales5.24
Price / Book2.64
EPS0.00
Book Value0.132
Revenue (TTM)10.08M
Gross Profit (TTM)7.38M
EBITDA1.60M
Profit Margin5.33%
Operating Margin20.71%
Return on Equity0.90%
Return on Assets1.64%
Shares Outstanding150.93M
Shares Float33.74M
Beta0.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
0.22Jan 9, 2020